Skip to content

COVAX expands with World Bank backing

The World Bank approved US$2 billion in financing for COVID-19 vaccines in 17 developing countries as part of a two-year US$12 billion package.

A photo illustration of medicinal syringes used to administer drugs, vaccines and blood transfusions
A photo illustration of medicinal syringes used to administer drugs, vaccines and blood transfusions (AN/Jernej Furman)

WASHINGTON (AN) — The World Bank approved US$2 billion in financing for COVID-19 vaccines in 17 developing countries on Tuesday, part of a two-year US$12 billion package aimed at helping poorer nations strengthen their vaccination systems.

The funding will support COVID-19 vaccinations in Afghanistan, Bangladesh, Cape Verde, Ecuador, El Salvador, Eswatini, Ethiopia, Gambia, Honduras, Ivory Coast, Lebanon, Mongolia, Nepal, Philippines, Rwanda, Tajikistan and Tunisia.

This article is for paying subscribers only

Join now

Already have an account? Log in

Latest